BindingDB logo
myBDB logout

30 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
10915041 2 Synthesis of fluorescent probes directed to the active site gorge of acetylcholinesterase.EBI The University of Montana
27908752 55 N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.EBI University of Ljubljana
27448914 30 Ameliorative effects of amide derivatives of 1,3,4-thiadiazoles on scopolamine induced cognitive dysfunction.EBI University Institute of Pharmaceutical Sciences
27598521 22 Discovery of Selective Inhibitors Targeting Acetylcholinesterase 1 from Disease-Transmitting Mosquitoes.EBI Ume£ University
26116179 5 Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents.EBI University of Ljubljana
25468034 33 Synthesis of aminoalkyl-substituted aurone derivatives as acetylcholinesterase inhibitors.EBI Kyung Hee University
25226236 19 Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor.EBI University of Ljubljana
24485122 9 Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors.EBI Kyung Hee University
23984975 29 Divergent structure-activity relationships of structurally similar acetylcholinesterase inhibitors.EBI Ume£ University
23941108 1 Casuarinines A-J, lycodine-type alkaloids from Lycopodiastrum casuarinoides.EBI Fudan University
8558505 77 A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors.EBI University of Missouri-St. Louis
23026084 17 Lead optimization studies towards the discovery of novel carbamates as potent AChE inhibitors for the potential treatment of Alzheimer's disease.EBI CSIR Central Drug Research Institute
18479118 113 Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.EBI Universit£ di Siena
18333606 29 Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.EBI Fudan University
15214773 76 Fragment-based drug discovery.EBI Sunesis Pharmaceuticals Inc.
7490731 45 Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds.EBI Eisai Company, Ltd.
1552502 74 Synthesis and cholinergic properties of bis[[(dimethylamino)methyl]furanyl] analogues of ranitidine.EBI University of South Carolina
18438404 13 Activation of the endocannabinoid system by organophosphorus nerve agents.EBI University of California
20137941 44 Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors.EBI Kyoto University
20137934 38 Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors.EBI Kyoto University
 27 Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine hydrochloride (E2020) and related compoundsEBI TBA
8709135 20 Identification of a 3-hydroxylated tacrine metabolite in rat and man: metabolic profiling implications and pharmacology.EBI Warner-Lambert Company
8027982 19 Syntheses and anticholinesterase activity of tetrahydrobenzazepine carbamates.EBI Pfizer Inc.
1469686 53 Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivatives.EBI Eisai Co., Ltd.
20846091 3 A FLT3-inhibitory constituent from the rhizomes of Anemarrhena asphodeloides.BDB Gyeongsang National University
14718605 8 Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.BDB Wyeth Research